257 related articles for article (PubMed ID: 36934894)
21. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
Ruggieri R; Rigo M; Naccarato S; Gurrera D; Figlia V; Mazzola R; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Vitale C; Stavreva N; Pressyanov DS; Stavrev P; Pellegrini R; Alongi F
Phys Med; 2020 Dec; 80():34-41. PubMed ID: 33091796
[TBL] [Abstract][Full Text] [Related]
22. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
24. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
25. A feasibility study of adaptive radiation therapy for postprostatectomy prostate cancer.
Meyers SM; Winter JD; Obeidi Y; Chung P; Menard C; Warde P; Fong H; McPartlin A; Parameswaran S; Berlin A; Bayley A; Catton C; Craig T
Med Dosim; 2024 Summer; 49(2):150-158. PubMed ID: 37985297
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
[TBL] [Abstract][Full Text] [Related]
27. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
[TBL] [Abstract][Full Text] [Related]
28. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
Devlin L; Dodds D; Sadozye A; McLoone P; MacLeod N; Lamb C; Currie S; Thomson S; Duffton A
Br J Radiol; 2020 Apr; 93(1108):20190789. PubMed ID: 31971829
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric and feasibility evaluation of a CBCT-based daily adaptive radiotherapy protocol for locally advanced cervical cancer.
Branco D; Mayadev J; Moore K; Ray X
J Appl Clin Med Phys; 2023 Jan; 24(1):e13783. PubMed ID: 36208134
[TBL] [Abstract][Full Text] [Related]
32. Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.
Tyagi N; Hipp E; Cloutier M; Charas T; Fontenla S; Mechalakos J; Hunt M; Zelefsky M
J Appl Clin Med Phys; 2019 Jul; 20(7):121-127. PubMed ID: 31206236
[TBL] [Abstract][Full Text] [Related]
33. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
[TBL] [Abstract][Full Text] [Related]
34. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
35. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
36. The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
Sengupta C; Skouboe S; Ravkilde T; Poulsen PR; Nguyen DT; Greer PB; Moodie T; Hardcastle N; Hayden AJ; Turner S; Siva S; Tai KH; Martin J; Booth JT; O'Brien R; Keall PJ
Med Phys; 2023 Jan; 50(1):20-29. PubMed ID: 36354288
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance guided adaptive post prostatectomy radiotherapy: Accumulated dose comparison of different workflows.
Hassan SP; de Leon J; Batumalai V; Moutrie Z; Hogan L; Ge Y; Stricker P; Jameson MG
J Appl Clin Med Phys; 2024 Apr; 25(4):e14253. PubMed ID: 38394627
[TBL] [Abstract][Full Text] [Related]
38. Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic Fossa.
Morgan HE; Wang K; Yan Y; Desai N; Hannan R; Chambers E; Cai B; Lin MH; Sher DJ; Wang J; Wang AZ; Jiang S; Timmerman R; Park CJ; Garant A
Pract Radiat Oncol; 2023; 13(4):e345-e353. PubMed ID: 36509197
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
